StockData
Mustang Bio, Inc. logo

Mustang Bio, Inc. (MBIO) stock

MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)

Close on Nov 18, 2026Market cap $2.88MP/E –Yield –

Mustang Bio r&d expenses

Research and development expenses are spending on new products and technology.

Mustang Bio's R&D Expenses for the twelve months ending Sep 30, 2024 was $14.37M, down 71.2% year over year. For fiscal 2024 it was $7.56M, down 81.3% from the year before. The highest annual figure on record is $62.48M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2024Dec 31, 2024$7.56M-81.3%
FY2023Dec 31, 2023$40.51M-35.2%
FY2022Dec 31, 2022$62.48M+25.3%
FY2021Dec 31, 2021$49.86M+33.9%
FY2020Dec 31, 2020$37.24M+23.9%
FY2019Dec 31, 2019$30.04M+42.4%
FY2018Dec 31, 2018$21.10M+165.7%
FY2017Dec 31, 2017$7.94M+221.8%
FY2016Dec 31, 2016$2.47M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024$57.00K-99.4%
Q2 FY2024Jun 30, 2024$4.36M-59.8%
Q1 FY2024Mar 31, 2024$3.80M-72.8%
Q4 FY2023Dec 31, 2023$6.15M-60.6%
Q3 FY2023Sep 30, 2023$9.53M-38.2%
Q2 FY2023Jun 30, 2023$10.84M-28.5%
Q1 FY2023Mar 31, 2023$14.00M-14.1%
Q4 FY2022Dec 31, 2022$15.60M+17.7%
Q3 FY2022Sep 30, 2022$15.42M+9.5%
Q2 FY2022Jun 30, 2022$15.16M+39.1%
Q1 FY2022Mar 31, 2022$16.29M+40.2%
Q4 FY2021Dec 31, 2021$13.26M+31.2%
Q3 FY2021Sep 30, 2021$14.08M+76.3%
Q2 FY2021Jun 30, 2021$10.90M+10.9%
Q1 FY2021Mar 31, 2021$11.62M+24.7%
Q4 FY2020Dec 31, 2020$10.11M+12.9%
Q3 FY2020Sep 30, 2020$7.99M+9.3%
Q2 FY2020Jun 30, 2020$9.83M+44.1%
Q1 FY2020Mar 31, 2020$9.31M+33.8%
Q4 FY2019Dec 31, 2019$8.95M+12.7%
Q3 FY2019Sep 30, 2019$7.31M+37.5%
Q2 FY2019Jun 30, 2019$6.82M+91.8%
Q1 FY2019Mar 31, 2019$6.96M+62.2%
Q4 FY2018Dec 31, 2018$7.94M+210.7%
Q3 FY2018Sep 30, 2018$5.32M+143.0%
Q2 FY2018Jun 30, 2018$3.56M+42.6%
Q1 FY2018Mar 31, 2018$4.29M+507.9%
Q4 FY2017Dec 31, 2017$2.56M+163.9%
Q3 FY2017Sep 30, 2017$2.19M+337.6%
Q2 FY2017Jun 30, 2017$2.49M–
Q1 FY2017Mar 31, 2017$706.00K–
Q4 FY2016Dec 31, 2016$968.00K–
Q3 FY2016Sep 30, 2016$500.00K–

More Mustang Bio figures

See a number that looks wrong?